Hummers, Eva

[["dc.bibliographiccitation.firstpage","448"],["dc.bibliographiccitation.lastpage","452"],["dc.contributor.author","Schmiemann, Guido"],["dc.contributor.author","Bleidorn, Jutta"],["dc.contributor.author","Hummers-Pradier, Eva"],["dc.contributor.author","Gágyor, Ildikó"],["dc.contributor.author","Kochen, Michael M."],["dc.contributor.editor","Kochen, Michael M."],["dc.date.accessioned","2021-09-06T10:13:22Z"],["dc.date.available","2021-09-06T10:13:22Z"],["dc.date.issued","2017"],["dc.description.edition","5"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/89284"],["dc.publisher","Thieme"],["dc.publisher.place","Stuttgart"],["dc.relation.isbn","978-3-13-141385-7"],["dc.relation.ispartof","Allgemeinmedizin und Familienmedizin"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.title","Schmerzen beim Wasserlassen"],["dc.type","book_chapter"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","810"],["dc.bibliographiccitation.issue","6"],["dc.bibliographiccitation.journal","Medical Decision Making"],["dc.bibliographiccitation.lastpage","818"],["dc.bibliographiccitation.volume","28"],["dc.contributor.author","Fischer, Thomas"],["dc.contributor.author","Fischer, Susanne"],["dc.contributor.author","Himmel, Wolfgang"],["dc.contributor.author","Kochen, Michael M."],["dc.contributor.author","Hummers-Pradier, Eva"],["dc.date.accessioned","2018-11-07T11:09:39Z"],["dc.date.available","2018-11-07T11:09:39Z"],["dc.date.issued","2008"],["dc.description.abstract","Background. The influence of patient characteristics on family practitioners' (FPs') diagnostic decision making has mainly been investigated using indirect methods such as vignettes or questionnaires. Direct observation-borrowed from social and cultural anthropology-may be an alternative method for describing FPs' real-life behavior and may help in gaining insight into how FPs diagnose respiratory tract infections, which are frequent in primary care. Objective. To clarify FPs' diagnostic processes when treating patients suffering from symptoms of respiratory tract infection. Methods. This direct observation study was performed in 30 family practices using a checklist for patient complaints, history taking, physical examination, and diagnoses. The influence of patients' symptoms and complaints on the FPs' physical examination and diagnosis was calculated by logistic regression analyses. Dummy variables based on combinations of symptoms and complaints were constructed and tested against saturated (full) and backward regression models. Results. In total, 273 patients (median age 37 years, 51% women) were included. The median number of symptoms described was 4 per patient, and most information was provided at the patients' own initiative. Multiple logistic regression analysis showed a strong association between patients' complaints and the physical examination. Frequent diagnoses were upper respiratory tract infection (URTI)/common cold (43%), bronchitis (26%), sinusitis (12%), and tonsillitis (11%). There were no significant statistical differences between \"simple heuristic'' models and saturated regression models in the diagnoses of bronchitis, sinusitis, and tonsillitis, indicating that simple heuristics are probably used by the FPs, whereas \"URTI/common cold'' was better explained by the full model. Conclusion. FPs tended to make their diagnosis based on a few patient symptoms and a limited physical examination. Simple heuristic models were almost as powerful in explaining most diagnoses as saturated models. Direct observation allowed for the study of decision making under real conditions, yielding both quantitative data and \"qualitative'' information about the FPs' performance. It is important for investigators to be aware of the specific disadvantages of the method (e. g., a possible observer effect)."],["dc.identifier.doi","10.1177/0272989X08315254"],["dc.identifier.isi","000261037800003"],["dc.identifier.pmid","18448702"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/13099"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/53054"],["dc.notes.intern","Merged from goescholar"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Sage Publications Inc"],["dc.publisher.place","Thousand oaks"],["dc.relation.conference","25th Annual Meeting of the Society-for-Medical-Decision-Making"],["dc.relation.eventlocation","Chicago, IL"],["dc.relation.issn","0272-989X"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.rights","Goescholar"],["dc.rights.uri","https://goescholar.uni-goettingen.de/licenses"],["dc.title","Family Practitioners' Diagnostic Decision-Making Processes Regarding Patients with Respiratory Tract Infections: An Observational Study"],["dc.type","conference_paper"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","655"],["dc.bibliographiccitation.issue","11"],["dc.bibliographiccitation.journal","Pneumologie"],["dc.bibliographiccitation.lastpage","661"],["dc.bibliographiccitation.volume","57"],["dc.contributor.author","Hummers-Pradier, Eva"],["dc.contributor.author","Frösch, A."],["dc.contributor.author","Kochen, Michael M."],["dc.date.accessioned","2021-08-26T13:15:39Z"],["dc.date.available","2021-08-26T13:15:39Z"],["dc.date.issued","2003-11"],["dc.description.abstract","The aim of the study was to assess the management of patients hospitalised for asthma with regard to the recommendations of the German Airway League, and the communication between hospital doctors and general practitioners (GPs). All records of patients discharged with asthma or COPD (ICD9) between 1/1996 and 6/1998 were retrieved (n = 169) in one general hospital. All patients whose asthma had been known in admission and was given as a reason for hospitalisation in the discharge letter were selected (n = 93). Treatment prescribed by the patients' GPs before hospitalisation as well as diagnostic procedures and treatment in hospital and the recommendations in the discharge letter were reviewed. Additionally the GPs were questioned with case vignettes. Before hospitalisation, most patients had been treated with theophyllin (66 %) and inhaled betamimetics (62 %), only 44 % had received topical and 29 % oral steroids by their GP. In hospital, lung function assessment was performed in only 8 % of the patients and there was no monitoring of the peak flow. The most commonly prescribed drugs were theophyllin (94 %), mucolytics (94 %) and antibiotics (82 %). Half of the patients (47 %) were discharged without adequate anti-inflammatory baseline treatment. The discharge letters did not contain detailed recommendations on future asthma management. There seems to be room for improvement with regard to the implementation of the German Airway League's recommendations both in hospital and in general practice: Few patients received systemic or inhaled steroids, whereas theophyllin and antibiotics were prescribed routinely. In hospital, airway obstruction was neither measured initially nor monitored. Communication between hospital doctors and GPs seems to be insufficient."],["dc.identifier.doi","10.1055/s-2003-44264"],["dc.identifier.pmid","14618509"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/88820"],["dc.language.iso","other"],["dc.relation.issn","0934-8387"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.title","Asthma - Management an der Schnittstelle zwischen Hausarzt und einem Krankenhaus der Grundversorgung"],["dc.title.alternative","Asthma management at the interface of general practice and hospital care"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","109"],["dc.bibliographiccitation.issue","2"],["dc.bibliographiccitation.journal","Das Gesundheitswesen"],["dc.bibliographiccitation.lastpage","114"],["dc.bibliographiccitation.volume","65"],["dc.contributor.author","Hummers-Pradier, Eva"],["dc.contributor.author","Simmenroth-Nayda, Anne"],["dc.contributor.author","Scheidt-Navel, C."],["dc.contributor.author","Scheer, N."],["dc.contributor.author","Fischer, T."],["dc.contributor.author","Niebling, W."],["dc.contributor.author","Kochen, Michael M."],["dc.date.accessioned","2018-11-07T10:41:17Z"],["dc.date.available","2018-11-07T10:41:17Z"],["dc.date.issued","2003"],["dc.description.abstract","Aims of the study: As part of an ongoing project on the utilisation of generic drugs in general practice we aimed at determining whether the transfer of prescriptions and patient characteristics from doctors' computerized medical records via the BDT (Behandlungsdatentrager) interface was feasible, and whether these data are suitable for research in pharmacoepidemiology. Methods: All 1,395 general practitioners from 6 regions in Germany were invited to participate in the 'generics project'; 232 (17%) agreed. The 17 software companies whose systems were used by the participating practices were asked to grant access to the BDT interface. For a prescription survey, doctors were supposed to export BDT files from two 3-month periods each in 2000 and 2001. Data were anonymised and relevant information extracted with a special programme. Results: So far, BDT data are available from 79 practices. They are suitable for practice- and patient-related prescribing analyses. By filter modifications, additional information (such as diagnoses, referrals; clinical findings or accounting codes) can be obtained. The procedure was well accepted if doctors and practice staff were assisted by computer experts. Some difficulties, however, were encountered in obtaining access to the BDT-interface from the software companies. Lack of standardisation of the BDT interface required additional conditioning of the data. Conclusion: The BDT interface offers an opportunity to export computerised patient records without the requirement of additional documentation. If routine data are more readily available for health services research, a standardised data structure and open access must be assured e.g. by centralised certification via the Federal statutory health organisation."],["dc.identifier.doi","10.1055/s-2003-37698"],["dc.identifier.isi","000181663400010"],["dc.identifier.pmid","12632320"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/46499"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Georg Thieme Verlag Kg"],["dc.relation.issn","0941-3790"],["dc.title","Medical care research based on family doctor routine data - Are interface-communicated treatment data feasible?"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","284"],["dc.bibliographiccitation.journal","Zeitschrift für Allgemeinmedizin"],["dc.bibliographiccitation.lastpage","286"],["dc.bibliographiccitation.volume","78"],["dc.contributor.author","Simmenroth-Nayda, Anne"],["dc.contributor.author","Niebling, W."],["dc.contributor.author","Bjerre, L. M."],["dc.contributor.author","Gleiter, C. H."],["dc.contributor.author","Jansen, R."],["dc.contributor.author","Ledig, T."],["dc.contributor.author","Kochen, Michael M."],["dc.contributor.author","Hummers-Pradier, Eva"],["dc.date.accessioned","2021-09-16T06:10:16Z"],["dc.date.available","2021-09-16T06:10:16Z"],["dc.date.issued","2002"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/89530"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.title","Empfehlungen zur Umstellung von Originalpräparaten auf Generika"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","256"],["dc.bibliographiccitation.issue","4"],["dc.bibliographiccitation.journal","Scandinavian Journal of Infectious Diseases"],["dc.bibliographiccitation.lastpage","261"],["dc.bibliographiccitation.volume","37"],["dc.contributor.author","Hummers-Pradier, Eva"],["dc.contributor.author","Koch, M."],["dc.contributor.author","Ohse, A. M."],["dc.contributor.author","Heizmann, W. R."],["dc.contributor.author","Kochen, Michael M."],["dc.date.accessioned","2018-11-07T11:14:11Z"],["dc.date.available","2018-11-07T11:14:11Z"],["dc.date.issued","2005"],["dc.description.abstract","A cross-sectional study was performed to determine the prevalence of antibiotic resistance in women with uncomplicated and complicated lower urinary tract infection ( UTI) in Germany. In 36 ( of 118 invited) general practices, urine cultures and resistance testing were performed during 4 months on all women presenting with symptoms of UTI. Each patient's symptoms, risk factors and treatment were documented. A total of 445 women were included, and their median age was 53 y. Complicating factors were present in 27% of women. Urine cultures were available for 430 patients. They were sterile in 23%, 53% had 10(5) cfu/ml or more, and 24% had 10(2) - 10(4) cfu/ml. E. coli was the most frequent pathogen (68%), followed by Enterococcus faecalis (10%) and Proteus spp. ( 10%). E. coli resistance levels were 25 - 40% for amoxicillin, co-amoxiclav, first generation oral cephalosporins, trimethoprim and co-trimoxazole. Nine percent were resistant to fluoroquinolones. E. coli resistance remained low for nitrofurantoin (2%) and third generation oral cephalosporins (3%). Odds for E. coli resistance to most antibiotics were 2 - 5 times higher in patients with complicating factors, and increased with age. Resistance levels to all common antibiotics were high even in unselected females with UTI in general practices. Older or complicated patients had a significantly higher risk for resistance."],["dc.identifier.doi","10.1080/00365540410021009"],["dc.identifier.isi","000228667600003"],["dc.identifier.pmid","15871164"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/54070"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.relation.issn","0036-5548"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.title","Antibiotic resistance of urinary pathogens in female general practice patients"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","503"],["dc.bibliographiccitation.journal","Zeitschrift für Allgemeinmedizin"],["dc.bibliographiccitation.lastpage","506"],["dc.bibliographiccitation.volume","80"],["dc.contributor.author","Chenot, Jean-François"],["dc.contributor.author","Fischer, T."],["dc.contributor.author","Simmenroth-Nayda, Anne"],["dc.contributor.author","Fassheber, S."],["dc.contributor.author","Hummers, Eva"],["dc.contributor.author","Aut, B."],["dc.contributor.author","Kernbach-Wighton, G."],["dc.contributor.author","Emmert, S."],["dc.contributor.author","Küntzel, H."],["dc.contributor.author","Klockgether-Radke, A. P."],["dc.contributor.author","Kochen, Michael M."],["dc.date.accessioned","2021-09-15T12:40:18Z"],["dc.date.available","2021-09-15T12:40:18Z"],["dc.date.issued","2004"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/89478"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.title","Interdisziplinärer Pilot-OSCE \"Medizinische Basisfähigkeiten\""],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","154"],["dc.bibliographiccitation.issue","475"],["dc.bibliographiccitation.journal","British Journal of General Practice"],["dc.bibliographiccitation.lastpage","155"],["dc.bibliographiccitation.volume","52"],["dc.contributor.author","Himmel, Wolfgang"],["dc.contributor.author","Hummers-Pradier, Eva"],["dc.contributor.author","Schumann, Henning"],["dc.contributor.author","Kochen, Michael M."],["dc.date.accessioned","2018-11-07T10:32:04Z"],["dc.date.available","2018-11-07T10:32:04Z"],["dc.date.issued","2002"],["dc.identifier.isi","000173854900017"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/44260"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Royal Coll General Practitioners"],["dc.relation.issn","0960-1643"],["dc.title","Predictive value of asthma medication to identify asthma sufferers - Authors' response"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dc.type.subtype","letter_note"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.issue","7"],["dc.bibliographiccitation.journal","European Journal of Clinical Pharmacology"],["dc.bibliographiccitation.volume","58"],["dc.contributor.author","Simmenroth-Nayda, Anne"],["dc.contributor.author","Gleiter, Christoph H."],["dc.contributor.author","Niebling, W."],["dc.contributor.author","Hummers-Pradier, Eva"],["dc.contributor.author","Kochen, Michael M."],["dc.date.accessioned","2018-11-07T09:58:42Z"],["dc.date.available","2018-11-07T09:58:42Z"],["dc.date.issued","2002"],["dc.format.extent","S97"],["dc.identifier.isi","000179032800109"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/37423"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Springer"],["dc.publisher.place","New york"],["dc.relation.conference","4th Annual Congress on Clinical Pharmacology"],["dc.relation.eventlocation","WIESBADEN, GERMANY"],["dc.relation.issn","0031-6970"],["dc.title","Switching brand name drugs to generic drugs in German general praxis"],["dc.type","conference_abstract"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.artnumber","30"],["dc.bibliographiccitation.journal","BMC Medicine"],["dc.bibliographiccitation.volume","8"],["dc.contributor.author","Bleidorn, Jutta"],["dc.contributor.author","Gagyor, Ildiko"],["dc.contributor.author","Kochen, Michael M."],["dc.contributor.author","Wegscheider, Karl"],["dc.contributor.author","Hummers-Pradier, Eva"],["dc.date.accessioned","2018-11-07T08:43:08Z"],["dc.date.available","2018-11-07T08:43:08Z"],["dc.date.issued","2010"],["dc.description.abstract","Background: Uncomplicated lower urinary tract infections (UTI) are usually treated with antibiotics. However, there is little evidence for alternative therapeutic options. This pilot study was set out 1) to make a rough estimate of the equivalence of ibuprofen and ciprofloxacin for uncomplicated urinary tract infection with regard to symptom resolution, and 2) to demonstrate the feasibility of a double-blind, randomized controlled drug trial in German general practices. Methods: We performed a double-blind, randomized controlled pilot trial in 29 German general practices. Eighty otherwise healthy women aged 18 to 85 years, presenting with at least one of the main UTI symptoms dysuria and frequency and without any complicating factors, were randomly assigned to receive either ibuprofen 3 x 400 mg oral or ciprofloxacin 2 x 250 mg (+1 placebo) oral, both for three days. Intensity of main symptoms-dysuria, frequency, low abdominal pain-was recorded at inclusion and after 4, 7 and 28 days, scoring each symptom from 0 (none) to 4 (very strong). The primary endpoint was symptom resolution on Day 4. Secondary outcomes were the burden of symptoms on Days 4 and 7 (based on the sum score of all symptoms), symptom resolution on Day 7 and frequency of relapses. Equivalence margins for symptom burden on Day 4 were pre-specified as +/-0.5 sum score points. Data analysis was done by intention to treat and per protocol. Randomization was carried out on patient level by computer programme in blocks of six. Results: Seventy-nine patients were analyzed (ibuprofen n = 40, ciprofloxacin n = 39). On Day 4, 21/36 (58.3%) of patients in the ibuprofen-group were symptom-free versus 17/33 (51.5%) in the ciprofloxacin-group. On Day 4, ibuprofen patients reported fewer symptoms in terms of total sum score (1; SD 1,42) than ciprofloxacin patients (1,3; SD 1,9), difference-0,33 (95% CI (-1,13 to + 0,47)), PP (per protocol) analysis. During Days 0 and 9, 12/36 (33%) of patients in the ibuprofen-group received secondary antibiotic treatment due to ongoing or worsening symptoms, compared to 6/33 (18%) in the ciprofloxacin-group (non significant). A total of 58 non-serious adverse events were reported, 32 in the ibuprofen group versus 26 in the ciprofloxacin group (non significant). Conclusions: Our results support the assumption of non-inferiority of ibuprofen compared to ciprofloxacin for treatment of symptomatic uncomplicated UTI, but need confirmation by further trials."],["dc.identifier.doi","10.1186/1741-7015-8-30"],["dc.identifier.isi","000279916700001"],["dc.identifier.pmid","20504298"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/5676"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/19886"],["dc.notes.intern","Merged from goescholar"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.relation.issn","1741-7015"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.rights","CC BY 2.0"],["dc.rights.uri","https://creativecommons.org/licenses/by/2.0"],["dc.title","Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection? - Results of a randomized controlled pilot trial"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.subtype","original_ja"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]